Inpatient Adolescent Contraception

Phase 0 Completed 25 enrolled Children's Mercy Hospital Kansas City

NaSingle-groupOpen-labelTreatment

Summary

The overall goal of this study is to refine and pilot test the investigators novel intervention to offer contraception counseling and initiation for hospitalized female adolescents, focusing on long acting reversible contraception (LARC).

Timeline

Start: 2020-12-10
Primary completion: 2022-04-01
Completion: 2023-04-04

Publications

Results Masonbrink AR, Noel-MacDonnell J, Staggs VS, Stancil S, Goggin K, Miller MK. Feasibility of a Contraception Intervention for Hospitalized Adolescents and Young Adults. Hosp Pediatr. 2023 Apr 1;13(4):337-344. doi: 10.1542/hpeds.2022-006996.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Etonogestrel	Unknown	0.12 mg	Other
Subject	Etonogestrel	Unknown	68 mg	Other
Subject	Levonorgestrel	Small molecule	1.5 mg	Oral
Subject	Norethindrone	Unknown	0.35 mg	Oral
Subject	Norgestimate	Small molecule	0.25 mg	Oral
Subject	Ulipristal Acetate	Unknown	30 mg	Oral
Subject	ethinyl estradiol	Small molecule	0.015 mg	Other
Subject	ethinyl estradiol	Small molecule	0.035 mg	Other
Subject	medroxyprogesterone acetate	Other / unclassified	150 mg	Intramuscular
Subject	norelgestromin	Unknown	—	Topical

Inpatient Adolescent Contraception

Summary

Timeline

Publications

Drugs

Indications